Literature DB >> 14994415

Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity.

Francisco Olán1, Margarita Portela, Carmen Navarro, Miguel Gaxiola, Luis H Silveira, Victor Ruiz, Manuel Martínez-Lavín.   

Abstract

Vascular endothelial growth factor (VEGF) is a cytokine overexpressed in hypoxic and malignant pathologies. VEGF induces vascular hyperplasia, new bone formation, and edema. These histological abnormalities characterize hypertrophic osteoarthropathy. We describe a case of pulmonary hypertrophic osteoarthropathy with high circulating VEGF levels. Removal of the lung tumor led to a dramatic disappearance of the skeletal abnormalities and to reduction of circulating VEGF levels. Histochemical studies of the excised tumor confirmed abnormal VEGF production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14994415

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Hypertrophic osteoarthropathy associated with gastrointestinal stromal tumour.

Authors:  L Silva; J L Andreu; P Muñoz; C Isasi; A López
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

Review 2.  [Hypertrophic osteoarthropathy. Bamberger-Marie disease].

Authors:  B Manger; A Lindner; K Manger; J Wacker; G Schett
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

3.  Hypertrophic osteoarthropathy: Detecting periosteal inflammation using Doppler ultrasound.

Authors:  Nobuya Abe; Hideki Kasahara; Takao Koike
Journal:  Eur J Rheumatol       Date:  2017-10-25

Review 4.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium.

Authors:  Sebastian G Bernardo; Jason J Emer; Mark E Burnett; Marsha Gordon
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

Review 6.  Paraneoplastic rheumatic syndromes.

Authors:  Csilla András; Zoltán Csiki; Andrea Ponyi; Arpád Illés; Katalin Dankó
Journal:  Rheumatol Int       Date:  2005-08-10       Impact factor: 2.631

7.  [Tibial pain and unilateral knee arthritis: Precursors of paraneoplastic arthropathy].

Authors:  U Lange; G Bachmann; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

Review 8.  Paraneoplastic syndromes in rheumatology.

Authors:  Bernhard Manger; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 9.  Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy.

Authors:  Sheila Nguyen; Mehrnaz Hojjati
Journal:  Clin Rheumatol       Date:  2010-10-09       Impact factor: 2.980

Review 10.  Primary hypertrophic osteoarthropathy: an update.

Authors:  Zeng Zhang; Changqing Zhang; Zhenlin Zhang
Journal:  Front Med       Date:  2013-01-23       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.